Your question on iHub the other day. I wonder w

Quote:

---

I wonder what percentage of CCR5 leronlimab blocks. We know from HIV that leronlimab can be overwhelmed by a mass proliferation of CCR5 targets. It's possible that an overexpression of miR-455-5p to reduce the number of CCR5 targets combined with leronlimab may produce an even better outcome than leronlimab alone.

---